CDC en Español

Search:

Global Migration and Quarantine

DGMQ Home > Immigrant, Refugee and Migrant Health > Lost Boys and Girls of Sudan > Presumptive Treatment

Table 1. Recommendations for Presumptive Treatment of Schistosomiasis and Strongyloidiasis among the Lost Boys and Girls of Sudan

 

Presumptive Treatment

CDC Testing for Schistosomiasis and
Strongyloidiasis

 

Group

Schistosomiasis

Strongyloidiasis

Before Therapy

After
Therapy

Needs
Follow-up After Therapy

Healthy

Praziquantel

20 mg/kg, two oral doses 6-8 hours apart

 

Albendazole

400 mg, oral doses, twice a day for 3 days

No

If patient becomes immune compromised: test for strongyloidiasis

If patient becomes immune compromised: test for strongyloidiasis

Immune compromised *

Praziquantel

20 mg/kg, two oral doses 6-8 hours apart

 

Albendazole

400 mg, oral doses, twice a day for 3 days

No

Strongyloidiasis testing at least 6 months after treatment

Testing for strongyloidiasis at least 6 months after treatment

Seizure disorder
not valuated for cysticercosis*

Evaluate for cysticercosis before giving therapy

 

Evaluate for cysticercosis before giving therapy

No

No

No

Seizure disorder not caused by cysticercosis

Praziquantel

20 mg/kg, two oral doses 6-8 hours apart

 

Albendazole

400 mg, oral doses, twice a day for 3 days

No

If patient becomes immune compromised: test for strongyloidiasis

If patient becomes immune compromised: test for strongyloidiasis

Cysticercosis*

No

 

No

Yes

No

No

Pregnant women*

No

No

Yes

No

No

* CDC can provide additional consultation as needed for these patients or for patients for whom presumptive therapy may have failed.

Page Last Modified: January 24, 2005
Safer Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov (TTY)